359 related articles for article (PubMed ID: 19506302)
1. AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.
Mingozzi F; Meulenberg JJ; Hui DJ; Basner-Tschakarjan E; Hasbrouck NC; Edmonson SA; Hutnick NA; Betts MR; Kastelein JJ; Stroes ES; High KA
Blood; 2009 Sep; 114(10):2077-86. PubMed ID: 19506302
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.
Ferreira V; Twisk J; Kwikkers K; Aronica E; Brisson D; Methot J; Petry H; Gaudet D
Hum Gene Ther; 2014 Mar; 25(3):180-8. PubMed ID: 24299335
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.
Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM
J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756
[TBL] [Abstract][Full Text] [Related]
4. CpG-depleted adeno-associated virus vectors evade immune detection.
Faust SM; Bell P; Cutler BJ; Ashley SN; Zhu Y; Rabinowitz JE; Wilson JM
J Clin Invest; 2013 Jul; 123(7):2994-3001. PubMed ID: 23778142
[TBL] [Abstract][Full Text] [Related]
5. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.
Brantly ML; Chulay JD; Wang L; Mueller C; Humphries M; Spencer LT; Rouhani F; Conlon TJ; Calcedo R; Betts MR; Spencer C; Byrne BJ; Wilson JM; Flotte TR
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16363-8. PubMed ID: 19706466
[TBL] [Abstract][Full Text] [Related]
6. CD8(+) T-cell responses to adeno-associated virus capsid in humans.
Mingozzi F; Maus MV; Hui DJ; Sabatino DE; Murphy SL; Rasko JE; Ragni MV; Manno CS; Sommer J; Jiang H; Pierce GF; Ertl HC; High KA
Nat Med; 2007 Apr; 13(4):419-22. PubMed ID: 17369837
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes.
Hui DJ; Basner-Tschakarjan E; Chen Y; Davidson RJ; Buchlis G; Yazicioglu M; Pien GC; Finn JD; Haurigot V; Tai A; Scott DW; Cousens LP; Zhou S; De Groot AS; Mingozzi F
Mol Ther; 2013 Sep; 21(9):1727-37. PubMed ID: 23857231
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
[TBL] [Abstract][Full Text] [Related]
9. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
Li H; Murphy SL; Giles-Davis W; Edmonson S; Xiang Z; Li Y; Lasaro MO; High KA; Ertl HC
Mol Ther; 2007 Apr; 15(4):792-800. PubMed ID: 17245353
[TBL] [Abstract][Full Text] [Related]
10. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans.
Parzych EM; Li H; Yin X; Liu Q; Wu TL; Podsakoff GM; High KA; Levine MH; Ertl HC
Hum Gene Ther; 2013 Apr; 24(4):431-42. PubMed ID: 23461589
[TBL] [Abstract][Full Text] [Related]
11. Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Ross CJ; Twisk J; Bakker AC; Miao F; Verbart D; Rip J; Godbey T; Dijkhuizen P; Hermens WT; Kastelein JJ; Kuivenhoven JA; Meulenberg JM; Hayden MR
Hum Gene Ther; 2006 May; 17(5):487-99. PubMed ID: 16716106
[TBL] [Abstract][Full Text] [Related]
12. Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopes.
Mays LE; Wilson JM
J Gene Med; 2009 Dec; 11(12):1095-102. PubMed ID: 19777488
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.
Siders WM; Shields J; Kaplan J; Lukason M; Woodworth L; Wadsworth S; Scaria A
Hum Gene Ther; 2009 Jan; 20(1):11-20. PubMed ID: 18828728
[TBL] [Abstract][Full Text] [Related]
15. The Effect of CpG Sequences on Capsid-Specific CD8
Xiang Z; Kurupati RK; Li Y; Kuranda K; Zhou X; Mingozzi F; High KA; Ertl HCJ
Mol Ther; 2020 Mar; 28(3):771-783. PubMed ID: 31839483
[TBL] [Abstract][Full Text] [Related]
16. The complex and evolving story of T cell activation to AAV vector-encoded transgene products.
Mays LE; Wilson JM
Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617
[TBL] [Abstract][Full Text] [Related]
17. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
[TBL] [Abstract][Full Text] [Related]
18. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.
McIntosh JH; Cochrane M; Cobbold S; Waldmann H; Nathwani SA; Davidoff AM; Nathwani AC
Gene Ther; 2012 Jan; 19(1):78-85. PubMed ID: 21716299
[TBL] [Abstract][Full Text] [Related]
19. Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.
Mueller C; Chulay JD; Trapnell BC; Humphries M; Carey B; Sandhaus RA; McElvaney NG; Messina L; Tang Q; Rouhani FN; Campbell-Thompson M; Fu AD; Yachnis A; Knop DR; Ye GJ; Brantly M; Calcedo R; Somanathan S; Richman LP; Vonderheide RH; Hulme MA; Brusko TM; Wilson JM; Flotte TR
J Clin Invest; 2013 Dec; 123(12):5310-8. PubMed ID: 24231351
[TBL] [Abstract][Full Text] [Related]
20. Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.
Cramer ML; Shao G; Rodino-Klapac LR; Chicoine LG; Martin PT
Hum Gene Ther; 2017 Jun; 28(6):493-509. PubMed ID: 28345428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
